| Vol. 15.20 – 26 May, 2021 |
| |
|
|
| Researchers identified significant genetic effects on 988/1,839 neuron/progenitor regulatory elements, with highly cell-type and temporally specific effects. [Nature Neuroscience] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors demonstrated that the adult hippocampal neural progenitors harbored an inflammatory potential that is proactively suppressed by transcription factor 4 (Tcf4). [Science Advances] |
|
|
|
| Researchers showed that Aß plaque-associated non-productive angiogenesis locally disassembled blood vessels, leaving behind vascular scars, and that microglial phagocytosis contributed to the local loss of endothelial cells. [Nature Communications] |
|
|
|
| Scientists identified targets of miR-9/9*-124 as reprogramming cells activated the neuronal program and revealed the role of miR-124 that directly promoted the expression of its target genes associated with neuronal development and function. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Researchers analyzed the collagen and matrix metalloproteinase 1 (MMP1) expression in Neurofibromatosis 1 cutaneous neurofibroma and found excessive expression of collagen and reduced expression of MMP1. [Cell Death & Disease] |
|
|
|
| Investigators silenced Ndufs4 in Neuro-2a cells and they observed shorter neurite lengths with decreased expression of synaptophysin. [Scientific Reports] |
|
|
|
| By analyzing retinal explants treated with selective ligands that target these receptors, researchers found that Sstr2-dependent somatostatin signaling induces a modest, dose-dependent inhibition of photoreceptor generation, while correspondingly increasing the relative fraction of primary progenitor cells. [Scientific Reports] |
|
|
|
| Researchers described a protocol for investigation of the effects of genetic manipulation on neural development through direct isolation of neural progenitors and neurons from the mouse embryonic neocortex by fluorescence-activated cell sorting. [Star Protocol] |
|
|
|
| Scientists defined myeloid cellular states in gliomas by longitudinal single-cell profiling and demonstrated their strict control by the tumor genotype: in isocitrate dehydrogenase (IDH)-mutant tumors, differentiation of infiltrating myeloid cells was blocked, resulting in an immature phenotype. [Nature Cancer] |
| |
|
|
|
| The authors discuss the potential of prostaglandins as candidates for the development of new therapeutic drugs for motor neuron diseases. [Cellular and Molecular Neurobiology] |
|
|
|
| Scientists review a potential role of the major cellular components of the blood-brain barrier (BBB), with a focus on the contribution of BBB disruption, in neurodegenerative disease progression. [Archives of Pharmacal Research] |
|
|
|
|
| VistaGen Therapeutics Inc. announced the initiation of its PALISADE Phase III clinical program with the PALISADE-1 Phase III trial, a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of PH94B for the acute treatment of anxiety in adults with Social Anxiety Disorder. [VistaGen Therapeutics Inc. (Globenews Wire, Inc.)] |
|
|
|
| BrainsWay Ltd. announced that Centene Corporation has published a positive coverage policy for Deep Transcranial Magnetic Stimulation treatment of obsessive-compulsive disorder using the BrainsWay Deep TMSâ„¢ system. [BrainsWay Ltd. (Globenews Wire, Inc.)] |
|
|
|
|
|
|
|
| Ulm University – Ulm, Germany |
|
|
|
| Icahn School of Medicine – Mount Sinai, New York, United States |
|
|
|
| Lerner Research Institute – Cleveland, Ohio, United States |
|
|
|
| St. Jude Children’s Research Hospital – Memphis, Tennessee, United States |
|
|
|
| Deep Genomics, Inc. – Toronto, Ontario, Canada |
|
|
|
|